Implant system selection directly influences the long-term success of treatment. The market contains hundreds of brands — but clinical research, 20+ year follow-up data, and independent trials show that only a handful of systems consistently deliver high outcomes. Straumann, Bredent and Nobel Biocare lead this elite group. Each differs in surface technology, implant design, immediate loading potential, and clinical indications — understanding these differences is the key to optimal treatment planning.
Three Systems at a Glance
Straumann — SLActive Surface and BLX System
The defining advantage of Straumann implantology is its SLActive surface technology. Compared with the standard sandblasted acid-etched (SLA) surface, SLActive is hydrophilic: blood proteins colonise the surface immediately after implant placement, and osteoblast migration is substantially accelerated. Clinical trials show that osseointegration with SLActive is shortened to 3–4 weeks — compared with 6–8 weeks for standard SLA. The Straumann BLX implant was specifically optimised for immediate loading: its convergent design achieves high primary stability (insertion torque ≥45–50 Ncm) at the moment of placement. For All-on-4, All-on-6, and single-tooth restorations, Straumann holds the broadest clinical evidence base and is the first-choice system for the majority of protocols.
Bredent copaSKY — Fast & Fixed Concept
Germany’s Bredent Medical offers an integrated system that comprehensively addresses full-arch edentulism. The copaSKY implant’s SAE surface provides reliable osseointegration; its convergent design achieves the high primary stability required by the Fast & Fixed protocol. Bredent’s distinguishing feature is its unified prosthetic-implant ecosystem: multi-unit abutments, bar constructions, and the full digital workflow are developed within the Bredent system. A same-day fixed prosthesis on 4–6 implants is the core clinical advantage of Bredent Fast & Fixed. For mid-range full-arch rehabilitation, Bredent offers an outstanding value proposition.
Nobel Biocare — Pro Arch and TiUnite Surface
Nobel Biocare is the originator of the All-on-4 concept — the company that developed the protocol with Prof. Paulo Maló in the late 1990s also accumulated the largest clinical dataset for it. The TiUnite surface — an oxidised titanium coating — carries both osteoconductive and osteoinductive properties. The Nobel Biocare Pro Arch protocol is a refined iteration of All-on-4, with optimised posterior implant angulation for improved long-term prosthetic stability. In terms of complication rates and long-term implant survival, Nobel Biocare systems are among the most extensively studied implants in the world.
Which System for Which Patient?
System selection is determined by the patient’s clinical profile, treatment protocol, and budget. For patients requiring accelerated osseointegration (controlled diabetes, smokers — elevated healing risk), Straumann SLActive is superior. For patients seeking full-arch Fast & Fixed treatment with excellent value, Bredent copaSKY is the leading choice. For patients who want evidence-based treatment backed by 25+ years of independent outcome data, Nobel Biocare All-on-4 / Pro Arch is unmatched in clinical documentation.
Conclusion
Straumann, Bredent and Nobel Biocare each offer distinct clinical advantages — there is no single “best” system, only the system best suited to each specific patient. At Digital Implant in Baku, all three systems are actively used; the optimal system is selected based on CBCT analysis and the individual patient’s clinical profile.